Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on healthcare commercial intelligence, and its news flow reflects this role in the U.S. healthcare market. The company regularly issues press releases detailing quarterly financial results, business performance and guidance, giving investors and analysts insight into trends in its subscription-based platform and related metrics.
News about Definitive Healthcare often includes earnings announcements for its fiscal quarters, where it discusses revenue, net loss or income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and cash flow metrics. These releases also highlight customer wins across end markets like medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms and healthcare advertising agencies.
Another important category of news involves corporate developments and leadership updates. The company reports inducement equity awards to senior leaders, changes in executive roles, and board-level updates, such as director resignations and committee appointments. These items provide context on how Definitive Healthcare structures its leadership and aligns compensation with its growth plans.
Definitive Healthcare also announces its participation in investor conferences and the timing of its quarterly financial results conference calls and webcasts. These updates indicate when management will discuss financial performance and outlook with the investment community.
By following the DH news feed, readers can monitor the company’s financial disclosures, leadership and governance changes, customer and market highlights, and investor relations events in one place. This page can be a useful reference for tracking how Definitive Healthcare communicates its progress and priorities over time.
Definitive Healthcare (Nasdaq: DH) published its 2023 Sustainability Report, showcasing its achievements in environmental, social, and governance (ESG) practices. Highlights include the retention of an ESG consultant to measure greenhouse gas emissions, and the closure of its least energy-efficient office. On the social front, the company improved diversity at the executive level, contributed 1,940 volunteer hours, and raised over $300,000 in charitable donations. In governance, Definitive Healthcare completed a SOC2 assessment and enhanced its cybersecurity and data privacy framework.
Definitive Healthcare, a leader in healthcare commercial intelligence, announced that Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference. The presentation is scheduled for June 4, 2024, at 9:10 a.m. ET. A live webcast will be available on the Definitive Healthcare investor relations website, with a replay accessible for a time. The announcement highlights the company's active role in industry events and its ongoing efforts to engage with investors and stakeholders.
Definitive Healthcare (Nasdaq: DH) announced the appointment of Kevin Coop as CEO, effective June 24, 2024. Coop replaces Jason Krantz, who served as Interim CEO and will remain as Executive Chairman. Coop brings over 30 years of experience in operations, product, and revenue growth, including leadership roles at DailyPay, Dun & Bradstreet, Black Knight, and Verisk Analytics. The company aims to leverage Coop's expertise to capitalize on the $10 billion healthcare commercial intelligence market, enhancing growth, innovation, and operational efficiency.
On May 14, 2024, Definitive Healthcare announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference. The presentation is scheduled for May 21, 2024, at 10:10 a.m. Eastern Time. A live webcast of the event will be available on the company's investor relations website, with a replay accessible for a period.
Definitive Healthcare reported a 7% increase in revenue to $63.5 million for the first quarter of fiscal year 2024. The company's adjusted EBITDA and net income also showed positive growth compared to the same period last year. Definitive Healthcare expanded its enterprise customer base and made significant customer wins. The Board of Directors approved a stock repurchase program of up to $20.0 million. The company issued financial guidance for the second quarter and full year 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.